Germany: Kicking Out the Drug Industry
Executive Summary
A fierce package of new cost-cutting measures in Germany is prompting drug firms to cut jobs and investment. Merck KGAA says it's now likely to build a new $300 million antibody factory in the US, not at home.
You may also be interested in...
Radiopharmaceuticals: A New Frontier In Precision Cancer Therapy
Growing interest in radioligand-based cancer therapies reflects the class’s unique advantages – including the ability to “see what you treat.”
The New Antibodies Revolutionizing Medicine
Nucleic acid-based therapies are poised to revolutionize medicine – just as antibodies did thirty years ago.
What Next In Oncology?
Oncology dominates pharma sales and pipeline league tables. But where is the next Keytruda?